- 2017 Korean Association for the Study of the Liver (KASL) Clinical Practice Guidelines of Chronic Hepatitis C: What's New?
-
Kim KA
- KMID: 2414456
- Korean J Gastroenterol.
- 2018 Jun;71(6):315-318.
- doi: 10.4166/kjg.2018.71.6.315
With the advent of highly effective direct-acting antiviral agents (DAA), the treatment of hepatitis C virus infections continues to change. The Korean Association for the Study of the Liver updated... -
- CITED
-
- Close
- SHARE
-
- Close
- Factors Associated with Improved Glycemic Control by Direct-Acting Antiviral Agent Treatment in Egyptian Type 2 Diabetes Mellitus Patients with Chronic Hepatitis C Genotype 4
-
Dawood AA, Nooh MZ, Elgamal AA
- KMID: 2392472
- Diabetes Metab J.
- 2017 Aug;41(4):316-321.
- doi: 10.4093/dmj.2017.41.4.316
BACKGROUND: The association of chronic hepatitis C virus (HCV) infection with type 2 diabetes mellitus (T2DM) was first reported in 1994. Little is known about the effect of direct-acting antiviral... -
- CITED
-
- Close
- SHARE
-
- Close
- Therapy with Direct-Acting Antiviral Agents for Hepatitis C-Related Liver Cirrhosis
-
Toshikuni
- KMID: 2412206
- Gut Liver.
- 2017 May;11(3):335-348.
- doi: 10.5009/gnl15458
Chronic hepatitis C virus (HCV) infection may eventually lead to liver cirrhosis (LC), a condition associated with a high risk of liver failure and hepatocellular carcinoma. Although interferon (IFN)-based therapy... -
- CITED
-
- Close
- SHARE
-
- Close
- Strategy for Hepatitis C Treatment in Liver Transplant Settings
-
Park JY
- KMID: 2364934
- J Korean Soc Transplant.
- 2016 Dec;30(4):149-154.
- doi: 10.4285/jkstn.2016.30.4.149
In patients with detectable virus at the time of liver transplantation, hepatitis C virus (HCV) infection always recurs on the graft, and 30% of patients have an aggressive clinical and... -
- CITED
-
- Close
- SHARE
-
- Close
- Renewed 2015 Clinical Practice Guidelines for Management of Hepatitis C by Korean Association for the Study of the Liver; What Has Been Changed? - Treatment of Patients with Decompensated Cirrhosis
-
Gwak GY
- KMID: 2373413
- Korean J Gastroenterol.
- 2016 Mar;67(3):137-141.
- doi: 10.4166/kjg.2016.67.3.137
HCV-related decompensated liver cirrhosis is a life-threatening illness with an average 5-year survival rate of 50%. Because these patients have higher risk of morbidity and mortality including development of hepatocellular... -
- CITED
-
- Close
- SHARE
-
- Close
